DSIP — 10 mg

About DSIP

Small historical human study · Limited clinical evidence

What it is studied for

Delta sleep-inducing peptide, investigated in sleep-regulation research.

What selected research found

A 1992 double-blind insomnia study reported some changes in objective sleep measures, but no improvement in subjective sleep quality; the authors did not find major therapeutic benefit.

Evidence limits

The peptide’s name is not proof of a reliable sleep effect. This small, short-term study does not establish durable efficacy or safety, or support human use of this material.

Selected sources

1. Bes et al., 1992 — Double-blind insomnia study ↗

References reviewed October 10, 2026.

Research use only. These notes summarize selected publications; they are not a systematic review, medical advice, dosing instructions, or evidence about this product lot. Clinical studies used controlled study formulations and supervision. AuraBio materials are not for human or veterinary use. Review the exact material identity and available lot documentation for your laboratory application.